Drugs / IR-101
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT07067346 | Jul 2025 → Jun 2026 overdue | neuroblastoma | Sichuan University | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | IR-101 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07067346 ↗ |
| Modality | Other / unclassified | “Radiopharmaceutical in Relapsed/Refractory Neuroblastoma” NCT07067346 ↗ |